Stock data

金萬林-創 (6645)

金萬林-創 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$83.65M, up 103.5% from a year earlier. EPS over the last four quarters totals -NT$2.24.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 金萬林-創 in Insightr